X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28046) 28046
Book Review (5836) 5836
Publication (2751) 2751
Book Chapter (195) 195
Conference Proceeding (64) 64
Dissertation (34) 34
Newsletter (31) 31
Book / eBook (26) 26
Magazine Article (9) 9
Government Document (6) 6
Web Resource (3) 3
Data Set (2) 2
Reference (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23096) 23096
humans (20498) 20498
female (14789) 14789
oncology (12085) 12085
cancer (8681) 8681
animals (7600) 7600
ovarian cancer (6353) 6353
middle aged (5898) 5898
epithelial-mesenchymal transition (5565) 5565
expression (5365) 5365
metastasis (5141) 5141
cell line, tumor (5024) 5024
ovarian neoplasms - pathology (4746) 4746
adult (4705) 4705
aged (4580) 4580
cell biology (4558) 4558
tumors (4041) 4041
mice (3952) 3952
carcinoma (3939) 3939
gene expression (3899) 3899
research (3778) 3778
prognosis (3665) 3665
breast-cancer (3456) 3456
apoptosis (3415) 3415
proteins (3389) 3389
carcinoma, ovarian epithelial (3172) 3172
obstetrics & gynecology (3105) 3105
chemotherapy (3085) 3085
male (3035) 3035
analysis (3002) 3002
biochemistry & molecular biology (2908) 2908
signal transduction (2905) 2905
breast cancer (2896) 2896
epithelial-cells (2803) 2803
gene expression regulation, neoplastic (2795) 2795
development and progression (2706) 2706
health aspects (2691) 2691
immunohistochemistry (2673) 2673
genetic aspects (2653) 2653
cell proliferation (2436) 2436
stem cells (2431) 2431
epithelial cells (2390) 2390
ovarian neoplasms - genetics (2363) 2363
neoplasms, glandular and epithelial - pathology (2345) 2345
ovarian neoplasms - drug therapy (2298) 2298
survival (2279) 2279
care and treatment (2269) 2269
article (2227) 2227
epithelial ovarian-cancer (2224) 2224
ovarian neoplasms - metabolism (2214) 2214
neoplasm staging (2015) 2015
epithelial ovarian cancer (1961) 1961
pathology (1955) 1955
aged, 80 and over (1934) 1934
research article (1898) 1898
epithelial cells - metabolism (1873) 1873
gene-expression (1866) 1866
cells (1810) 1810
medicine (1799) 1799
invasion (1770) 1770
multidisciplinary sciences (1736) 1736
growth (1716) 1716
kinases (1708) 1708
proliferation (1663) 1663
physiological aspects (1591) 1591
e-cadherin (1490) 1490
medicine, research & experimental (1489) 1489
medical prognosis (1473) 1473
activation (1470) 1470
down-regulation (1457) 1457
risk factors (1445) 1445
genes (1398) 1398
in-vitro (1387) 1387
studies (1353) 1353
biology (1343) 1343
cell growth (1336) 1336
cancer research (1332) 1332
neoplasm invasiveness (1332) 1332
metastases (1322) 1322
cell cycle (1313) 1313
mutation (1310) 1310
breast neoplasms - pathology (1283) 1283
surgery (1279) 1279
cell adhesion & migration (1269) 1269
hematology, oncology and palliative medicine (1267) 1267
ovarian neoplasms - mortality (1265) 1265
up-regulation (1249) 1249
neoplasms, glandular and epithelial - drug therapy (1238) 1238
review (1231) 1231
neoplasms, glandular and epithelial - genetics (1223) 1223
retrospective studies (1222) 1222
science (1218) 1218
epithelial cells - pathology (1208) 1208
phosphorylation (1207) 1207
angiogenesis (1194) 1194
cancer therapies (1193) 1193
progression (1193) 1193
emt (1177) 1177
colorectal-cancer (1176) 1176
medicine & public health (1174) 1174
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27732) 27732
Chinese (120) 120
French (111) 111
Korean (103) 103
German (64) 64
Spanish (39) 39
Japanese (24) 24
Polish (19) 19
Russian (11) 11
Czech (8) 8
Turkish (7) 7
Hungarian (5) 5
Persian (5) 5
Bulgarian (4) 4
Portuguese (4) 4
Danish (3) 3
Italian (3) 3
Hebrew (2) 2
Croatian (1) 1
Dutch (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2018, Volume 68, Issue 4, pp. 284 - 296
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2010, Volume 177, Issue 3, pp. 1053 - 1064
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 3, pp. 230 - 240
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2473 - 2483
Incorporating bevacizumab in a chemotherapy regimen (7.5 mg/kg every 3 weeks for five or six cycles) and then continuing bevacizumab alone for a total of 12... 
ANTIANGIOGENIC THERAPY | MEDICINE, GENERAL & INTERNAL | ASCITES | SOLID TUMORS | FACTOR EXPRESSION | PHASE-II | MONOCLONAL-ANTIBODY | PROGNOSTIC-SIGNIFICANCE | TUMOR ANGIOGENESIS | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Ovarian Neoplasms - mortality | Bevacizumab | Young Adult | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Carboplatin - administration & dosage | Combined Modality Therapy | Neoplasms, Glandular and Epithelial - surgery | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Quality of Life | Aged | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Intravenous administration | Body weight | Cancer therapies | Survival | Patients | Angiogenesis | Chemotherapy | Surgery | Paclitaxel | Monoclonal antibodies | Carboplatin | Vascular endothelial growth factor | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 24, pp. 2888 - 2898
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 7, pp. 610 - 618
In patients with ovarian cancer and thrombocytosis, tumors may express interleukin-6, which stimulates production of thrombopoietin. The increase in platelets... 
MEDICINE, GENERAL & INTERNAL | ANGIOGENESIS | GROWTH | MICE | MODEL | INTERLEUKIN-6 | THROMBOPOIETIN | ASPIRIN | Blood Platelets - immunology | Interleukin-6 - antagonists & inhibitors | Humans | Antibodies, Monoclonal - therapeutic use | Ovarian Neoplasms - complications | Thrombopoietin - blood | Neoplasms, Glandular and Epithelial - blood | Interleukin-6 - blood | Female | Paraneoplastic Syndromes | Ovarian Neoplasms - drug therapy | Disease Models, Animal | Signal Transduction | Kaplan-Meier Estimate | Proportional Hazards Models | Ovarian Neoplasms - blood | Thrombocytosis - etiology | Thrombopoietin - antagonists & inhibitors | Mice, Knockout | Neoplasms, Glandular and Epithelial - complications | Disease-Free Survival | Animals | Platelet Count | Receptors, Interleukin-6 - deficiency | Interleukin-6 - immunology | Neoplasms, Glandular and Epithelial - drug therapy | Mice | Thrombocythemia | Usage | Medical examination | Blood platelets | Causes of | Thrombocytosis | Research | Diagnosis | Health aspects | Risk factors | Blood | Ovarian cancer | Animal models | Cytokines | Liver | Paracrine signalling | Data processing | Multivariate analysis | Patients | Thrombopoietin | Cell adhesion & migration | Interleukin 6 | Angiogenesis | Paclitaxel | Plasma levels | Platelets | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
ENDOCRINOLOGY, ISSN 0013-7227, 09/2009, Volume 150, Issue 9, pp. 4003 - 4011
Epigenetic aberrations, including DNA methylation, histone modifications, and micro-RNA dysregulation, are now well established in the development and... 
PROMOTER HYPERMETHYLATION | HISTONE DEACETYLASE INHIBITOR | PROGRESSION-FREE SURVIVAL | DNA METHYLATION MARKERS | ENDOCRINOLOGY & METABOLISM | TUMOR-SUPPRESSOR GENE | CISPLATIN RESISTANCE | MICRORNA EXPRESSION | EPITHELIAL OVARIAN | REDUCED EXPRESSION | FREQUENT INACTIVATION
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 01/2011, Volume 9, Issue 1, pp. 82 - 113
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article